Catalyst Wire Dossier Catalyst Wire Dossier

Rg3-enriched Korean Red Ginseng and American Ginseng combination

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rg3-enriched Korean Red Ginseng and American Ginseng combination, covering 2018-11-21 to 2018-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension in Type 2 Diabetes [Phase 1, Phase 2]

See pricing